Table 1.

Distribution of patients by INSS, IRDFs, INRG, and N-Myc status.

Total	34
INSS Stage
III	7
IV	27
IRDFs
≤1	4
≥2	22
INRG Stage
intermediate-risk	8
high-risk	26
N-Myc
wild-type	17
mutated	11
NI	6